Why Invest With PetVivo?
Spryng™ with OsteoCushion™ Technology is within a booming industry that continues to increase in growth, need, and sales.
Osteoarthritis (OA) affects 1 out of 4 dogs and over half of all horses . This is an addressable opportunity in companion animal OA therapeutics market.
Large and Growing Market
68% of US households own a pet and stats show a $99B US pet spend as of 2020.
Positioned to Scale
New facility, positioned to scale, with capacity to produce up 500K units annually = up to 100M in revenue.
NEWS AND PRESS
FREQUENTLY ASKED QUESTIONS
What is PetVivo Holdings, Inc.?
What is spryng™ with OsteoCushion™ Technology?
What is the difference between PetVivo and spryng™ with OsteoCushion™ Technology?
Spryng™ with OsteoCushion™ Technology is the name of a product we provide.
How can I learn more about spryng™ and Petvivo?
What if I have more questions?